Drug Profile
Beclometasone intravitreal
Alternative Names: AGN 208 397; Beclometasone intravitreousLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Allergan
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
- Mechanism of Action Immunosuppressants; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Retinal disorders; Retinal oedema
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 06 Dec 2018 Discontinued - Phase-I/II for Retinal oedema in Canada, Australia, South Africa, Israel, USA (Intravitreous)
- 06 Dec 2018 Discontinued - Phase-II for Retinal disorders in Italy (Intravitreous)